Details of the Drug

General Information of Drug (ID: DMEU2F4)

• Drug Name: S-16961
• Synonyms: S-16961-1; (R,S)-1,2-O-Bis(hexadecanoyl)-3-O-(3-pyridylcarbonyl)glycerol; (d,l)-1,2-O-Dipalmitoyl-3-O-nicotinoylglycerol

Indication

Disease Entry	ICD 11	Status	REF
Hyperlipidaemia	5C80	Discontinued in Phase 1	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C41H71NO6
  Canonical SMILES: CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C1=CN=CC=C1)OC(=O)CCCCCCCCCCCCCCC
  InChI: InChI=1S/C41H71NO6/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-31-39(43)46-35-38(36-47-41(45)37-30-29-33-42-34-37)48-40(44)32-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h29-30,33-34,38H,3-28,31-32,35-36H2,1-2H3
  InChIKey: HOTHIZPJZICUAJ-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 178041
  CAS Number: 153874-14-7
  TTD ID: D0XK1F

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008215)